Tanner 0 6 0 6 B-clinical_variable
stage 7 12 7 12 I-clinical_variable
II 13 15 13 15 B-lower_bound
- 15 16 15 16 O
V 16 17 16 17 B-upper_bound

age 0 3 18 21 B-age
10 4 6 22 24 B-lower_bound
- 6 7 24 25 O
21 7 9 25 27 B-upper_bound

male 0 4 28 32 B-gender
and 5 8 33 36 I-gender
female 9 15 37 43 I-gender
adolescents 16 27 44 55 O
/ 27 28 55 56 O
young 28 33 56 61 O
adults 34 40 62 68 O

overweight 0 10 69 79 O
or 11 13 80 82 O
obese 14 19 83 88 O
( 20 21 89 90 O
body 21 25 90 94 B-bmi
mass 26 30 95 99 I-bmi
index 31 36 100 105 I-bmi
â‰¥85th 37 42 106 111 O
percentile 43 53 112 122 I-lower_bound
for 54 57 123 126 O
age 58 61 127 130 B-age
and 62 65 131 134 O
sex 66 69 135 138 O
) 69 70 138 139 O

pregnancy 0 9 140 149 B-pregnancy

syndromic 0 9 150 159 B-chronic_disease
obesity 10 17 160 167 I-chronic_disease
( 18 19 168 169 O
such 19 23 169 173 O
as 24 26 174 176 O
Prader 27 33 177 183 B-chronic_disease
Willi 34 39 184 189 I-chronic_disease
, 39 40 189 190 O
hypothalamic 41 53 191 203 B-chronic_disease
obesity 54 61 204 211 I-chronic_disease
, 61 62 211 212 O
or 63 65 213 215 O
Laurence- 66 75 216 225 B-chronic_disease
Moon 76 80 226 230 I-chronic_disease
- 80 81 230 231 I-chronic_disease
Biedl 81 86 231 236 I-chronic_disease
) 86 87 236 237 O

use 0 3 238 241 O
of 4 6 242 244 O
medications 7 18 245 256 B-treatment
that 19 23 257 261 O
adversely 24 33 262 271 O
affect 34 40 272 278 O
glucose 41 48 279 286 B-clinical_variable
metabolism 49 59 287 297 I-clinical_variable
( 60 61 298 299 O
such 61 65 299 303 O
as 66 68 304 306 O
glucocorticoid 69 83 307 321 B-clinical_variable
- 83 84 321 322 O
containing 84 94 322 332 O
medications 95 106 333 344 O
or 107 109 345 347 O
atypical 110 118 348 356 B-clinical_variable
antipsychotics 119 133 357 371 I-clinical_variable
) 133 134 371 372 O

